The 95% Effective Dose of Dexmedetomidine to Induce Adequate Sedation in Patients with Chronic Insomnia Disorder: a Biased Coin Design Up-and-down Sequential Allocation Trial

Overview

Journal BMC Anesthesiol

Publisher Biomed Central

Specialty Anesthesiology

Date 2024 Oct 11

PMID 39394067

Authors

Mengya Li

Guifeng Li

Qifang Li

Qing Cai

Affiliations

Soon will be listed here.

Abstract

Background: Chronic insomnia disorder is a common sleep disorder. Previous studies have reported increased demand for anesthetics in patients with chronic insomnia disorder. However, few studies have investigated the effective dose of dexmedetomidine for sedation in patients with chronic insomnia disorder. We aimed to determine the 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder.

Methods: This is a biased coin design up-and-down sequential allocation trial in patients aged 18-65 years with chronic insomnia disorder (n = 60). The dose of dexmedetomidine for the subsequent patient was determined based on the response of the previous patient, with an interval of 0.1 µg/kg. Sedation was assessed using the bispectral index. The 95% effective dose was calculated using isotonic regression.

Results: The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder was 1.75 (95% confidence interval, 1.70-1.94) µg/kg. Four patients (6.7%) experienced bradycardia and no other adverse events were observed during the study.

Conclusions: The 95% effective dose of dexmedetomidine to induce adequate sedation in patients with chronic insomnia disorder was 1.75 µg/kg.

Trials Registration: Chinese Clinical Trial Registry (ChiCTR2200063212); first registered 01/09 /2022.

References

Demiri M, Antunes T, Fletcher D, Martinez V . Perioperative adverse events attributed to α2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis. Br J Anaesth. 2019; 123(6):795-807. DOI: 10.1016/j.bja.2019.07.029. View

Wichniak A, Wierzbicka A, Walecka M, Jernajczyk W . Effects of Antidepressants on Sleep. Curr Psychiatry Rep. 2017; 19(9):63. PMC: 5548844. DOI: 10.1007/s11920-017-0816-4. View

Ohayon M, Reynolds 3rd C . Epidemiological and clinical relevance of insomnia diagnosis algorithms according to the DSM-IV and the International Classification of Sleep Disorders (ICSD). Sleep Med. 2009; 10(9):952-60. PMC: 3715324. DOI: 10.1016/j.sleep.2009.07.008. View

Aldrete J, Kroulik D . A postanesthetic recovery score. Anesth Analg. 1970; 49(6):924-34. View

Morin C, Benca R . Chronic insomnia. Lancet. 2012; 379(9821):1129-41. DOI: 10.1016/S0140-6736(11)60750-2. View

Giovannitti Jr J, Thoms S, Crawford J . Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth Prog. 2015; 62(1):31-9. PMC: 4389556. DOI: 10.2344/0003-3006-62.1.31. View

Kim J, Kim W, Kim H, Kil H . Adequate sedation with single-dose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose-response study by age group. BMC Anesthesiol. 2015; 15:17. PMC: 4429489. DOI: 10.1186/1471-2253-15-17. View

Kasuya Y, Govinda R, Rauch S, Mascha E, Sessler D, Turan A . The correlation between bispectral index and observational sedation scale in volunteers sedated with dexmedetomidine and propofol. Anesth Analg. 2009; 109(6):1811-5. DOI: 10.1213/ANE.0b013e3181c04e58. View

Stylianou M, Flournoy N . Dose finding using the biased coin up-and-down design and isotonic regression. Biometrics. 2002; 58(1):171-7. DOI: 10.1111/j.0006-341x.2002.00171.x. View

10.

Ohayon M . OBSERVATION OF THE NATURAL EVOLUTION OF INSOMNIA IN THE AMERICAN GENERAL POPULATION COHORT. Sleep Med Clin. 2010; 4(1):87-92. PMC: 2699022. DOI: 10.1016/j.jsmc.2008.12.002. View

11.

Wang C, Zhang H, Fu Q . Effective dose of dexmedetomidine as an adjuvant sedative to peripheral nerve blockade in elderly patients. Acta Anaesthesiol Scand. 2018; 62(6):848-856. PMC: 6001622. DOI: 10.1111/aas.13087. View

12.

Blake M, Trinder J, Allen N . Mechanisms underlying the association between insomnia, anxiety, and depression in adolescence: Implications for behavioral sleep interventions. Clin Psychol Rev. 2018; 63:25-40. DOI: 10.1016/j.cpr.2018.05.006. View

13.

Morin C, Jarrin D . Epidemiology of Insomnia: Prevalence, Course, Risk Factors, and Public Health Burden. Sleep Med Clin. 2022; 17(2):173-191. DOI: 10.1016/j.jsmc.2022.03.003. View

14.

Xu B, Li Z, Zhou D, Li L, Li P, Huang H . The Influence of Age on Sensitivity to Dexmedetomidine Sedation During Spinal Anesthesia in Lower Limb Orthopedic Surgery. Anesth Analg. 2017; 125(6):1907-1910. DOI: 10.1213/ANE.0000000000002531. View

15.

Chen Z, Tang R, Zhang R, Jiang Y, Liu Y . Effects of dexmedetomidine administered for postoperative analgesia on sleep quality in patients undergoing abdominal hysterectomy. J Clin Anesth. 2017; 36:118-122. DOI: 10.1016/j.jclinane.2016.10.022. View

16.

Riemann D, Nissen C, Palagini L, Otte A, Perlis M, Spiegelhalder K . The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015; 14(5):547-58. DOI: 10.1016/S1474-4422(15)00021-6. View

17.

Ki S, Lee D, Lee W, Cho K, Han Y, Lee J . Verification of the performance of the Bispectral Index as a hypnotic depth indicator during dexmedetomidine sedation. Anesth Pain Med (Seoul). 2021; 17(1):44-51. PMC: 8841253. DOI: 10.17085/apm.21065. View

18.

Pace N, Stylianou M . Advances in and limitations of up-and-down methodology: a précis of clinical use, study design, and dose estimation in anesthesia research. Anesthesiology. 2007; 107(1):144-52. DOI: 10.1097/01.anes.0000267514.42592.2a. View

19.

Erden V, Abitagaoglu S, Guler C, Dogan Z, Kirgezen S, Abut Y . Insomnia may increase anesthetic requirement. J Clin Anesth. 2016; 34:367-72. DOI: 10.1016/j.jclinane.2016.05.020. View

20.

Chamadia S, Hobbs L, Marota S, Ibala R, Hahm E, Gitlin J . Oral Dexmedetomidine Promotes Non-rapid Eye Movement Stage 2 Sleep in Humans. Anesthesiology. 2020; 133(6):1234-1243. PMC: 7657975. DOI: 10.1097/ALN.0000000000003567. View